Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

NCT04616456 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04616456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 30, 2020
Completion date
January 30, 2022
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, multiple system atrophy (msa) with orthostatic hypotension, multiple system atrophy, cerebellar variant, multiple system atrophy, parkinson variant (disorder)